GPR183 senses 7α,25-OHC to drive T reg differentiation and tumor immune evasion via AXL-JAK2-STAT5 signaling
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
We identify that the oxysterol 7α,25-dihydroxycholesterol (7α,25-OHC), produced by Vimentin + stromal cells, acts through GPR183 to promote T reg differentiation and suppressive identity.
Limitation the authors admit
Last, GPR183 antagonism modestly enhances anti-PD-1 efficacy in a model-dependent manner and prevents therapy-induced T reg expansion.
Appeared: Sunday, November 1. Science Advances. Peer-reviewed journal.